BioLegend from Revvity

BioLegend from Revvity provides researchers with high-quality life science reagents. Learn more about Revvity at:

[BioLegend from Revvity @BioLegend]

Thank you for joining us at #FOCIS 2026. We enjoyed the conversations and are proud to support your clinical immunology research. See you next year at the Federation of Clinical Immunology Societies meeting in Boston! https://t.co/0xMpGBNbDu

[BioLegend from Revvity @BioLegend]

The Whitlow/218 linker can be used in the construction of CAR-T cells. We now offer monoclonal antibody W24150D to detect this linker, representing the first of many reagents designed to analyze CAR-T cells and accelerate cancer breakthroughs. https://t.co/TGcj5ezh52

[BioLegend from Revvity @BioLegend]

Congrats to Jiyoung Yun, winner of our Customer Travel Award, who will present on engineering CAR intracellular signaling domains to guide iPSC differentiation toward functional CD4⁺ and CD8⁺ CAR-T cells at a conference in Cold Spring Harbor! Learn more: https://t.co/21GHAGKwPO

[BioLegend from Revvity @BioLegend]

We had an amazing time collaborating with you at #CYTO2026! Thank you for coming by to discuss your research with us. Learn more about our latest products, including StarBright™ UV and Spark PLUS antibody conjugates, by visiting our website: https://t.co/4NV0V7y25w

[BioLegend from Revvity @BioLegend]

Drop by our poster presentation at #CYTO2026 where Henry Bene (board P152) on June 9th from 5–7pm. He’ll discuss the characterization of CD34+ hematopoietic stem cells from human umbilical cord blood using the Cellaca™ PLX image cytometer. https://t.co/kAcXLODc4l

[BioLegend from Revvity @BioLegend]

FOCIS 2026 is underway! Visit us to connect with our team, discuss the latest immunology advances in our 46-color flow cytometry panel workshop, and learn how our solutions support translational and clinical research. https://t.co/2gP4Ef21xV

[BioLegend from Revvity @BioLegend]

If you’re at #CYTO2026, don’t forget to attend our talk by Rebecca Nickle, who will be covering the construction of a 46-color flow cytometry panel characterizing human immune cells. Meet us in room 2C on June 9th from 12:15 – 1:15 p.m.

[BioLegend from Revvity @BioLegend]

We are ready to see you at CYTO 2026! Come by booth 401 to chat with us about our latest innovations in flow cytometry and microscopy applications. https://t.co/fKHkdJ0m34 #CYTO2026

[BioLegend from Revvity @BioLegend]

Missed #AAI2026? Download our new scientific poster on the simultaneous detection of transcription factors and RNA using TotalSeq™ antibodies with 10x Genomics Chromium Single Cell Flex Gene Expression. https://t.co/a54L9Ix7iy

[BioLegend from Revvity @BioLegend]

In our latest blog, we look at recent studies showcasing how multimodal applications and TotalSeq™ single-cell protein detection can provide new perspectives on CAR T-cell therapy by integrating complementary datasets from the same cell. https://t.co/7dUaXsyTHH

[BioLegend from Revvity @BioLegend]

Podoplanin has broad tissue distribution but may serve as a useful marker for tumor studies given its involvement in lymphatic vessel formation and tumor metastasis. Explore our antibodies for microscopy applications like IHC and IBEX. https://t.co/DkP4fIW36Z

[BioLegend from Revvity @BioLegend]

We are happy to launch StarBright™ UltraViolet 605 and 665 antibody conjugates. While StarBright UV665 offers comparable brightness to BUV661, StarBright UV605 outshines BUV615 in our staining index testing. Learn more about these dyes at: https://t.co/fZIpQ3LTAk

[BioLegend from Revvity @BioLegend]

Congrats to Atia Batool, winner of BioLegend's 2026 Customer Travel Award! They will present on airway macrophage metabolism in pulmonary fibrosis at the #ICMI (International Congress of Mucosal Immunology). Learn more: https://t.co/5ljFDSmm9v #PulmonaryResearch

[BioLegend from Revvity @BioLegend]

Our new Fatty Acid Uptake Probe is a synthetic precursor that measures fatty acid transport activity in flow cytometry and live-cell imaging. Reveal how these important sources of energy and complex lipids can affect cell metabolism. https://t.co/SVU80mafHR

[BioLegend from Revvity @BioLegend]

Congrats to Alessandro Gasparetto, winner of our 2026 Customer Travel Award, who presented his groundbreaking work on Merkel cell carcinoma and https://t.co/qHG6RQIAFV cell therapy at #AACR2026. https://t.co/2sETCCz2xM

[BioLegend from Revvity @BioLegend]

We’re heading to FOCIS 2026! Join us at the Federation of Clinical Immunology Societies meeting in San Francisco to hear our scientific workshop and explore new tools advancing immune profiling. https://t.co/TdAGUQK3dp

[BioLegend from Revvity @BioLegend]

Congrats to Araba Abaidoo-Myles, PhD student at VCU, winner of BioLegend's 2026 AAI Travel Award! They specialize in infectious diseases, immunology, and molecular cell biology, working to improve disease diagnosis and develop novel therapies. https://t.co/s0QJF3EbIq

[BioLegend from Revvity @BioLegend]

Protein phosphorylation regulates nearly all cellular processes by dynamically modifying protein structure and function. Discover our phospho antibodies to detect this mechanism in flow cytometry, western blotting, and fluorescent microscopy. https://t.co/V350zzPKMF

[BioLegend from Revvity @BioLegend]

Check out our new publication, where BioLegend scientists created the first commercially available monoclonal antibody (S22019F) specific for KIR2DS1, a marker that can regulate NK cell function via HLA ligands. Learn more about our testing at: https://t.co/dqhTOK0XZz

[BioLegend from Revvity @BioLegend]

Expand your cancer research with our recombinant IC proteins, from current targets PD-L1 and CTLA-4 to emerging ones such as TIGIT. They undergo rigorous quality testing, functional validation, and also come in Avi-tag biotinylated formats. https://t.co/M1hMHu2p8n